Comparative effectiveness of transurethral resection of bladder tumors and office fulguration for recurrent bladder tumors.
暂无分享,去创建一个
[1] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[2] J. Oh,et al. An analysis of the efficacy, safety, and cost-effectiveness of fulguration under local anesthesia for small-sized recurrent masses: a comparative analysis to transurethral resection of bladder tumors in a matched cohort. , 2013, Journal of endourology.
[3] S. Shariat,et al. Cost‐effective treatment of low‐risk carcinoma not invading bladder muscle , 2013, BJU international.
[4] W. Lowrance,et al. Office-based Bladder Tumor Fulguration and Surveillance: Indications and Techniques. , 2013, The Urologic clinics of North America.
[5] G. Dalbagni,et al. Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm. , 2004, The Journal of urology.
[6] B. Birch,et al. A prospective trial of flexible cystodiathermy for recurrent transitional cell carcinoma of the bladder. , 1999, The Journal of urology.
[7] M. Babjuk,et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder. , 2013, European urology.
[8] M. Soloway,et al. Expectant management of small, recurrent, noninvasive papillary bladder tumors. , 2003, The Journal of urology.
[9] F. Keeley,et al. Audit of safety, efficacy, and cost-effectiveness of local anaesthetic cystodiathermy. , 2010, Annals of the Royal College of Surgeons of England.
[10] E. Wallen,et al. Conservative management of low risk superficial bladder tumors. , 2008, The Journal of urology.
[11] M. Benson,et al. Muscle-invasive urothelial carcinoma of the bladder. , 2007, Urology.